Australian based company Neuren pharmaceuticals is now recruiting for the second ever clinical trial into Angelman syndrome in Australia. Sites are located in Melbourne, Sydney and Brisbane.
- Confirmed diagnosis of Angelman syndrome (not mosaic)
- Male & Female
- Stable seizure profile
- >12kg weight
Further details and eligibility criteria can be found at angelmanstudy.com.au/ & clinicaltrials.gov/